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Abstract We analyzed the expression of aquaporins (AQPs) in
the small intestine to elucidate their functions, and found that
AQP9, which had not previously been detected there, is present
in duodenum, jejunum, and ileum. AQP9 is expressed in colon
as well, but not in stomach. Also, its expression in these intes-
tinal sections is limited to the basolateral membranes of a goblet
cell subset. Our ¢nding that AQP9 is present speci¢cally in
goblet cells as mucus-secreting cells suggests its involvement in
the synthesis and/or secretion of a certain kind of mucus which
may protect the intestinal surface and smooth the £ow of intes-
tinal contents.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Aquaporins (AQPs) refer to water channels involved in
water transport across the plasma membrane [1,2]. In humans,
they comprise 11 subtypes that constitute the AQP family.
Not only water but also small solutes can be transported by
some subtypes of this family [2]. We have suggested the in-
volvement of AQP(s) in digestion after food intake by ¢nding
the expression of AQP4 in acid- and pepsinogen-secretory
cells of human stomach [3]. The small intestine as well may
have some functional AQP(s) involved in food digestion, since
this organ has an activity for absorbing the major part of
imbibed and food-borne water and for excreting undigested
residues by secretion [4,5]. Indeed, information is available
that AQP1, AQP3, AQP4, AQP5, AQP7, AQP8 and AQP10
are expressed in the small intestine [4,6,7], but their functions
remain unknown.
In the present study, we investigated the expression of other
AQPs in the small intestine, particularly in the ileum, and
found that AQP9 as a new intestinal AQP subtype is ex-
pressed speci¢cally in a subset of the mucus-secreting goblet
cells. Here we also report on its possible functions deduced
from histochemical studies.
2. Materials and methods
2.1. RT-PCR
Human small intestine poly A RNA was purchased from Clontech.
Mouse small intestine total RNA was extracted from adult male
mouse (C57BL/6J, 10 weeks old) using ISOGEN (Nippon Gene)
and then treated with DNase I. The RNA samples obtained were
reverse-transcribed using a random primer and a ¢rst-strand cDNA
synthesis kit (Amersham Biosciences). The following primer sets were
prepared for ampli¢cation of cDNA fragments of AQPs: human
AQP1 (hAQP1), 5P-GCATCACCTCCTCCCTG-3P and 5P-CATC-
CAGGTCATACTCCT-3P (forward and reverse primer, respectively)
for a 429 bp fragment; hAQP2, 5P-CCATTACACCGGCTGCTC-3P
and 5P-GGAGAAGCCACCACTAGC-3P for a 523 bp fragment;
hAQP3, 5P-ATCGTGTGTGTGCTGGCC-3P and 5P-AGGGTGGAT-
CGTGAAGGG-3P for a 462 bp fragment; hAQP4, 5P-CTGGTCAT-
GGTCTCCTGG-3P and 5P-CCTTCTTCTCCTCTCCCC-3P for a 468
bp fragment; hAQP5, 5P-GTGGGCAACCAGATCTCG-3P and 5P-
CGTCAGGCTCATACGTGC-3P for a 509 bp fragment; hAQP7,
5P-GCCCTGGAGGAAGTTTCC-3P and 5P-ACCCACCACCAGTT-
CTCC-3P for a 447 bp fragment; hAQP8, 5P-GTGACAGTCCAGG-
AGCAG-3P and 5P-AAGCAGGCCCAAGCAGTG-3P for a 490 bp
fragment; hAQP9, 5P-CTGAACAGTGGCTGTGCC-3P and 5P-GCG-
TTATTCTGGGGGGTG-3P for a 478 bp fragment; and mouse
AQP9 (mAQP9), 5P-TTGTCGGGGCTGCAACTG-3P and 5P-CCCA-
CTACATGATGACGC-3P for a 552 bp fragment. PCR ampli¢cations
(30 s at 94‡C, 30 s at 60‡C, 1 min at 72‡C, 40 cycles) were performed
in the presence of 0.5 WM of each primer, 800 WM dNTPs, 1U ExTaq
bu¡er and 25 U/ml ExTaq DNA polymerase (Takara Bio). The PCR
products obtained were cloned into the pBluescript II SK (3) vector
(Stratagene) and their nucleotide sequences were con¢rmed using a
DNA sequencer (Applied Biosystems).
2.2. Tissue sampling
For in situ hybridization, adult male mice (C57BL/6J, 7^10 weeks
old) were sacri¢ced by cervical dislocation. Tissue samples were rap-
idly excised on ice, washed in ice-cold phosphate-bu¡ered saline
(PBS), and immersed in O.C.T. compound (Sakura). After freezing
in liquid nitrogen, the samples were cut into 7 Wm thick sections with
a cryostat (Leica). Sections were mounted on glass slides coated with
3-aminopropyltriethoxysilane (Matsunami Glass Ind.). For immuno-
histochemistry and periodic acid Schi¡’s stain (PAS)/alcian blue stain-
ing, mice were deeply anesthetized with sodium pentobarbital and
then perfused with 4% paraformaldehyde in PBS. Tissue samples
were excised, post-¢xed in 4% paraformaldehyde in PBS (30^60 min
on ice), and cryoprotected with 30% (w/v) sucrose in PBS on ice.
Frozen sections were prepared as described above.
2.3. In situ hybridization
A 570 bp cDNA fragment for mAQP9 was ampli¢ed from the ¢rst
strand cDNA of mouse liver using the following primer set: forward
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primer with BamHI site-added 5P-TTGGATCCCTTTGTCGGGGC-
TGCAACTG-3P and reverse primer with Hind III site-added 5P-
CCAAGCTTCCCACTACATGATGACGCTG-3P. A 485 bp cDNA
fragment for mouse MUC2 was ampli¢ed from the ¢rst strand cDNA
of mouse small intestine using the following primer set: forward prim-
er with BamHI site-added 5P-GTGGATCCGGGAAGATGCACT-
CATGG-3P and reverse primer with Hind III site-added 5P-CCAA-
GCTTTCTCCCAGGTACACCATG-3P. PCR ampli¢cations were
performed as described above, and the fragments obtained were
cloned into pBluescript II SK (3) vector. Digoxigenin (DIG)-labeled
riboprobe preparation and hybridization were basically according to
Matsumoto et al. [8,9]. In brief, DIG-labeled antisense and sense
riboprobes were synthesized using DIG RNA Labeling MIX (Roche
Applied Science) from BamHI-linearized template by T7 RNA poly-
merase (Stratagene) and from HindIII-linearized template by T3 RNA
polymerase (Stratagene), respectively. These probes were then treated
with alkaline ‘sizing’ bu¡er (42 mM NaHCO3, 63 mM Na2CO3 and
5 mM dithiothreitol (DTT)) for 40 min at 60‡C to yield cRNA frag-
ments with an average length of about 150 bases. Fresh frozen tissue
sections were ¢xed with 4% paraformaldehyde in PBS for 15 min,
prehybridized for 2 h at 58‡C with 50% (v/v) formamide, 5U SSC
and 40 Wg/ml denatured salmon testis DNA (Sigma). Hybridization
with a riboprobe was carried out for about 40 h at 58‡C in 50% (v/v)
formamide, 5U SSC, 5U Denhardt’s solution, 500 Wg/ml denatured
salmon testis DNA (Sigma), 250 Wg/ml Escherichia coli tRNA (Sig-
ma), and 1 mM DTT. After hybridization, the sections were washed
twice for 5 min each at 58‡C with 5U SSC, and twice for 30 min each
at 58‡C with 0.2U SSC. Samples were incubated for 1 h with blocking
reagent (Roche Applied Science) and then for 1 h with anti-DIG
antibody conjugated with alkaline phosphatase (Roche Applied Sci-
ence) (1:500) in the same blocking reagent. For color reaction,
5-bromo-4-chloro-3-indolyl phosphate (Sigma) and nitro-blue-tetra-
zolium (Sigma) were used.
2.4. Western blot analysis
For Western blotting, ileum, liver and kidney were excised from
adult male mice (C57BL/6J, 7^10 weeks old) and homogenized in
10 mM Tris^HCl (pH 8.0), 1 mM EDTA, containing 1 mM phenyl-
methylsulfonyl £uoride (Nacalai tesque), 1 Wg/ml leupeptin (Sigma)
and 1 Wg/ml pepstatin A (Sigma). Homogenates were centrifuged at
800Ug for 10 min. The supernatants were applied to SDS^PAGE and
transferred to Immobilon P membranes (Millipore). The membranes
Fig. 1. AQP expression in the small intestine. A: RT-PCR of hAQPs in the small intestine. PCR ampli¢cation was performed as described in
Section 2. Primer sets used for reaction and estimated lengths of ampli¢ed fragments are as follows: lane 1, hAQP9 (478 bp); lane 2, hAQP1
(429 bp); lane3, hAQP2 (523 bp); lane 4, hAQP3 (462 bp); lane 5, hAQP4 (468 bp); lane 6, hAQP5 (509 bp); lane7, hAQP7 (447 bp); and
lane 8, hAQP8 (490 bp). Fragments corresponding to the cDNA for hAQP9 (lane 1) and several AQP subtypes were ampli¢ed from human
small intestine cDNA (white arrowheads). B: RT-PCR of mAQP9 in the small intestine. PCR ampli¢cation was performed using template-de-
rived mouse small intestine total RNA after (lane +) or before (lane 3) the reverse transcription reaction. Fragments corresponding to mAQP9
were ampli¢ed only when the RNA sample was reverse transcribed (white arrowhead).
Fig. 2. Localization of mAQP9 mRNA in mouse ileum. A^C: In situ hybridization for mAQP9 mRNA expression in the ileum was carried
out using a DIG-labeled antisense riboprobe. A: An ileum section as a whole is shown at low-magni¢cation. Expression of the mAQP9
mRNA appeared in a scattered fashion throughout the section. Note that two images from the same sample are combined into one. B: High-
magni¢cation image of A. Signals indicating the expression of mAQP9 are detected in epithelial cells of both villi and crypts (arrowheads).
C: High-magni¢cation image of part of a villus. Signals are localized in several limited epithelial cells (arrowheads). D: No speci¢c signal was
detected with a sense riboprobe. Scale bars indicate 300 Wm (A), 100 Wm (B,D), and 10 Wm (C).
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were incubated for 1 h at room temperature with blocking solution
(5% skim milk in Tris-bu¡ered saline containing 0.05% Tween 20)
prior to incubation overnight at 4‡C with a⁄nity-puri¢ed rabbit
anti-AQP9 antibody (Alpha Diagnostics) (1:200) in blocking solution.
The membranes were then incubated for 1 h at room temperature
with secondary horseradish peroxidase-conjugated donkey anti-rabbit
IgG (Amersham Biosciences) in blocking solution. Detection by
chemiluminescence was performed using SuperSignal West Dura Ex-
tended Duration Substrate (Pierce) and Hyper¢lm MP (Amersham
Life Science). For preabsorption of anti-AQP9 antibody, the antibody
was incubated with an excess amount of antigenic peptide for 24 h at
4‡C. Control experiments were carried out using the preabsorbed anti-
AQP9 under the same conditions as described above.
2.5. Immunohistochemistry and PAS/alcian blue staining
For immunohistochemistry, paraformaldehyde-¢xed tissue sections
were incubated in methanol containing 0.3% H2O2 for 30 min at 4‡C.
Sections were incubated for 1 h at room temperature with 3% normal
goat serum (NGS) and 1% bovine serum albumin (BSA) in PBS con-
taining 0.1% Triton X-100 prior to incubation overnight at 4‡C with
a⁄nity-puri¢ed rabbit anti-AQP9 antibody (1:600) in dilution solu-
tion (1% NGS, 1% BSA in PBS containing 0.1% Triton X-100). Sec-
tions were incubated for 1 h at room temperature with secondary
biotinylated goat anti-rabbit IgG (Vector Laboratories) in dilution
solution and then incubated for 30 min with avidin^biotin^peroxidase
complex (Vector Laboratories). A metal enhanced 3,3P-diaminobenzi-
dine tetrahydrochloride (DAB) substrate kit (Pierce) was used as a
chromogenic substrate. For alcian blue counter staining, DAB-stained
sections were incubated for 5 min with alcian blue staining solution
(Nacalai tesque). For PAS/alcian blue staining, paraformaldehyde-
¢xed tissue sections were incubated in methanol for 30 min at 4‡C,
reacted with a Schi¡’s PAS kit (PolyScience), and then incubated for
5 min with alcian blue staining solution.
3. Results
3.1. RT-PCR analysis of the expression of AQPs in the small
intestine
Using an RT-PCR technique, we ¢rst examined the expres-
sion of AQP subtypes in human small intestine. The already
reported intestinal AQP subtypes, hAQP1, hAQP3, hAQP4,
hAQP5, hAQP7 and hAQP8, were found as ampli¢ed bands
at the expected positions (Fig. 1A). In addition, hAQP9,
which had not been identi¢ed by Northern blot analysis prob-
ably because its expression level is very low, was found to be
present in the small intestine (Fig. 1A). Since, however, it was
technically and ethically di⁄cult to obtain human small-intes-
tinal sections for histological analysis, we carried out further
studies with mouse tissue, which permits in-depth experimen-
tation. It was then necessary to con¢rm the expression of
AQP9 in the mouse small-intestinal sample as well, prior to
carrying out the following histochemical staining studies. We
conducted an RT-PCR experiment using mouse small-intesti-
nal mRNA and an mAQP9-speci¢c primer set, and readily
detected an ampli¢ed band at the position expected for
mAQP9 mRNA (Fig. 1B). For con¢rmation, the fragments
from the bands were submitted to nucleotide sequence analy-
ses (data not shown).
3.2. Expression of mAQP9 in the small intestine
We then carried out detailed histochemical analyses for
Fig. 3. Detection of mAQP9 protein in mouse ileum. A,B: Western blot analysis of a roughly puri¢ed membrane fraction of the ileum, liver
and kidney was carried out using a⁄nity-puri¢ed anti-AQP9 antibody (A) or anti-AQP9 antibody preabsorbed with an antigenic peptide (B).
A: In the liver lane, there are bands assigned to the monomeric 32 and 35 kDa forms of AQP9, and a faint band consistent with a dimeric
form of 65 kDa. In the ileum lane only the form with lower mobility was seen. No signal was detected in the kidney lane. B: No band was de-
tected when preabsorbed anti-AQP9 antibody was used. C,D: Immunostaining was carried out with a mouse ileum section using anti-AQP9
antibody (C) or anti-AQP9 antibody preabsorbed with an antigenic peptide (D). High magni¢cation image of a villus is shown. C: Basolateral
membranes of several apical expanded epithelial cells are stained. D: No positive staining result was obtained when preabsorbed anti-AQP9
antibody was used. Scale bars indicate 10 Wm (C,D).
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AQP9 using mouse samples. First, in situ hybridization was
performed to examine the mAQP9 expression in the ileum.
Using a DIG-labeled antisense riboprobe, signals were ob-
served throughout the ileum (Fig. 2A), especially in both villi
and crypt epithelia (Fig. 2B). However, the signals were scat-
tered in the epithelia (Fig. 2A^C). No signal was seen in a
control experiment with a sense probe in any part of the ileum
(Fig. 2D).
Subsequently, immunohistochemical analysis of mAQP9
protein was conducted using anti-AQP9 antibody. First, we
carried out a Western analysis using a roughly puri¢ed mem-
brane fraction from mouse ileum. A similar sample from liver
was used as a positive control because it is known to express
AQP9 [10,11], and another sample from kidney was used as a
negative control. In the liver lane, there were major bands
corresponding to ca. 32 kDa and to ca. 35 kDa, and a faint
band corresponding to ca. 65 kDa (Fig. 3A). A band corre-
sponding to ca. 32 kDa is due to the mAQP9 monomer, and a
band corresponding to ca. 35 kDa to the sugar adduct
mAQP9 monomer. A band corresponding to ca. 65 kDa is
probably due to the mAQP9 dimmer because it was reported
that mAQP9 dimmer undissociated by the SDS was detected
in the same position [12]. Furthermore, none of the bands
observed in the liver lane could be detected when a similar
analysis was conducted using anti-AQP9 antibody that had
been preabsorbed with the antigenic peptide (Fig. 3B). These
results are consistent with the published data [12,13], and in-
dicate that this antibody can be useful to detect mAQP9 pro-
tein. In the ileum lane, there was only a major band corre-
sponding to ca. 65 kDa and bands corresponding to ca. 32
kDa and to ca. 35 kDa were not detected (Fig. 3A). The
presence of this major band indicates the expression of
mAQP9 protein in ileum.
Next, this antibody was used for immunohistochemical
analysis of mouse ileum sections. Staining of the ileum clearly
showed the presence of mAQP9 in some epithelial cells (Fig.
3C). Preabsorption with the antigenic peptide abolished the
signal (Fig. 3D). The frequency of the immunoreactive cells,
i.e. mAQP9-IR(+) cells, was similar to that of cells recognized
as positive by in situ hybridization (Fig. 2A^C). Each of the
mAQP9-IR(+) cells was found to exhibit an expanded shape
at the apical portion, and to be stained by the mAQP9 anti-
body in the basolateral membrane only (Fig. 3C). Both the
frequency and the shape of the cells led us to speculate that
these mAQP9-positive cells are goblet cells.
We focused our investigation on goblet cells in the mouse
ileum and employed the characterized marker MUC2 as a
mucoprotein secreted from goblet cells. In situ hybridization
for MUC2 and PAS/alcian blue staining for glycoproteins
showed signals scattered in the epithelia of both villi and
crypts (Fig. 4B,C). A scattered distribution pro¢le of
MUC2-positive cells in epithelia was found to resemble that
of mAQP9-positive cells as described above (Fig. 4A). This
result suggests that the mAQP9-positive cells are goblet cells,
although the population of mAQP9-positive cells was smaller
than that of MUC2-positive cells (Fig. 4A^C).
Furthermore, we recon¢rmed our ¢ndings by double-stain-
ing with anti-AQP9 antibody and acidic mucus staining alcian
blue on the same ileum section. Most of the mAQP9-IR(+)
cells were positively stained by alcian blue (Fig. 4D, arrow-
heads). Most of these cells were thus identi¢ed as goblet cells,
although a few of the mAQP9-IR(+) cells were alcian blue-
negative (Fig. 4D, white arrowhead).
Fig. 4. Speci¢cation of mAQP9 expressing-cells in mouse ileum by staining of goblet cells. A,B: In situ hybridizations of mouse ileum sections
were carried out using antisense riboprobes for mAQP9 (A) or mMUC2 (B). Adjacent ileum sections were used for A and B. Staining of both
mAQP9 and mMUC2 is seen in several epithelial cells of both villi and crypts (arrowheads). C: PAS/alcian blue staining was carried out with
a mouse ileum section. PAS/alcian blue-stained goblet cells are also present in both villi and crypts (arrowheads). D: Ileum section after immu-
nostaining with anti-mAQP9 antibody and counterstaining with alcian blue. mAQP9-immunoreactivity (IR) (brown) is sometimes overlapped
with alcian blue staining (blue) in some apically expanded epithelial cells (arrowheads). Apical expanded epithelial cells are also detected show-
ing only mAQP9-IR (white arrowhead) or only alcian blue staining (arrows). Scale bars indicate 100 Wm (A^C) and 10 Wm (D).
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3.3. Expression of mAQP9 mRNA in gastrointestinal goblet
cells
Not only ileum but also other intestinal sections, i.e. duo-
denum, jejunum, and colon, have goblet cells. Other digestive
tissues also contain mucus-secreting cells, e.g. surface mucous
cells in the stomach. It therefore seemed possible that mAQP9
would be expressed in these mucus-secreting cells and also in
goblet cells of di¡erent origins. We therefore investigated the
expression of mAQP9 in various digestive organs. In situ hy-
bridization with an mAQP9 antisense probe was applied to
mouse stomach, duodenum, jejunum, and colon sections, and
then PAS/alcian blue staining of these sections was carried out
to identify goblet and mucus-secreting cells. No positive re-
sults were obtained with stomach (Fig. 5A,F), while mAQP9
was clearly detected in duodenum and jejunum as well as in
ileum epithelia (Fig. 5B^D). In situ hybridization with the
mAQP9 sense probe gave no signal in slices of mouse stom-
ach, duodenum, jejunum, or colon (data not shown). Positive
cells expressing mAQP9 were scattered from the tips of villi to
the bases of crypts (Fig. 5B^D). With respect to the popula-
tion of the mAQP9-positive cells, the observed relationship is
as follows: duodenum6 jejunum6 ileum (Fig. 5B^D), prob-
ably re£ecting that the goblet cell population increases in the
same order (Fig. 5G^I). Our data also show that the popula-
tion of mAQP9-positive cells is not equivalent to that of gob-
let cells, indicating the existence of mAQP9 in a portion of
goblet cells. In the colon, however, goblet cells resided
throughout the crypt epithelia (Fig. 5J), though mAQP9 sig-
nals appeared on epithelial cells in the bottom portion of the
crypt (Fig. 5E,J). mAQP9 was found to be expressed in a
subset of goblet cells, although its expression pattern in the
colon di¡ers from that in the small intestine. These results
suggest that mAQP9 is expressed only in a subset of mucus-
secreting goblet cells, not in all the mucus-secreting cells.
4. Discussion
Our present study is the ¢rst that reports on the presence of
AQP9 in mouse colon as well as human and mouse small
intestine, and also on its speci¢c localization in a subset of
intestinal goblet cells. It has been reported that AQP9 is ex-
pressed in hepatocytes, leukocytes, immature spermatocytes,
Leydig cells and astrocytes, among other cells types [11,14,15],
which have well-developed smooth endoplasmic reticula
(ERs). In contrast to these observations, our present report
concerns the presence of AQP9 in goblet cells which does not
have developed smooth ERs, but have well-developed rough
ERs. This report also describes that AQP9 in the goblet cell
subset is localized in the basolateral membrane (Fig. 3C),
whereas AQP9 is localized in the apical membrane of the
above-mentioned non-intestinal cell types [11,15].
AQP9 is expressed in only a subset of goblet cells in small
Fig. 5. mAQP9 mRNA localization in mucus-secreting cells of mouse gastrointestinal tract. In situ hybridization using mAQP9 antisense ribo-
probe (A^E) and PAS/alcian blue staining (F^J) were carried out with stomach (A,F), duodenum (B,G), jejunum (C,H), ileum (D,I), and colon
(E,J) sections. In the stomach, no mAQP9 signal is found even in a mucous secretion cell (A,F, arrow). In duodenum, jejunum, ileum, and co-
lon, mAQP9 signals are localized in goblet cells (arrowheads in B^E, arrows in G^J). Note that the population of mAQP9 expressing-cells in
these tissues is smaller than that of goblet cells (B^E, G^J). mAQP9 expressing-cells in duodenum, jejunum and ileum are scattered in goblet
cells of both villi and crypts (B^D), whereas colon mAQP9 expressing-cells are localized only in goblet cells at the bottom portion of crypts
(E). Scale bars indicate 100 Wm (A^D,F^I) and 50 Wm (E,J).
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intestine and colon (Fig. 5). Possible explanations for this
limited domain of expression may be as follows: First, in
goblet cells not expressing AQP9, some other AQP subtype(s)
may possibly be expressed and exert a similar function. Sec-
ond, the AQP9-expressing goblet cells may be functionally
di¡erent from the other goblet cells. At present, we think
that the second possibility is more likely because di¡erent
goblet cells show di¡erent drug responses [16,17], and the
mucus contained in goblet cells has a variety of mucin sub-
types [18,19], pH [19] and response toward immunostaining
[20].
AQP9 is a recently reported AQP subtype, also being an
aquaglyceroporin which can transport glycerol, urea, etc., as
well as water [10,11,21]. Though the physiological function of
AQP9 is a subject of speculation for many research groups
[12,13,15,22], its real roles in vivo are still unclear. However,
our ¢nding clari¢es that the expression of AQP9 takes place
speci¢cally in goblet cells whose functions are well de¢ned.
Probably, therefore, AQP9 may function for the synthesis
and/or secretion of mucus. It is reported that, unlike the other
AQPs, this aquaporin AQP9 may have a characteristic ability
to permeate glycerol, mannitol, sorbitol, and other low-mo-
lecular-weight solutes [11,21]. Because of the ability, Nihei et
al. [15] have suggested that AQP9 in hepatocytes and testis
Leydig cells participates in the rapid cellular uptake and re-
lease of various small-size lipid and/or cholesterol metabolites
through their apical membrane. It is known that goblet cells
in the intestine can take up extracellular glucose, galactose,
galactosamine, etc., through their basolateral membranes and
use them for the synthesis of mucus [23]. This means that
AQP9 may participate in the transport these solutes, together
with water, to and from goblet cells.
The mucus secreted from the goblet cells is known to take
part in protecting the intestinal surface, smoothing the £ow of
intestinal contents [24,25]. Such important functions of goblet
cells have long been known and, in addition, a recent ¢nding
that tumor frequency is higher in MUC2-knockout mice [26]
accentuates the importance of these cells. Also, it has been
reported that goblet cells, which are characterized by their
synthesis and secretion of mucus, can be regulated by hor-
mones, drugs, etc. [16,27^29]. On the other hand, the expres-
sion, localization and function of AQPs are also known to be
hormone-dependent [30,31], as in the case of AQP9 [32,33].
There may thus be a close correlation between mucus and
AQP9. The present study is thus the ¢rst that clearly suggests
the involvement of the newly found intestinal AQP, AQP9, in
the synthesis and secretion of a certain kind of mucus which
may protect the intestinal surface and smooth the £ow of
intestinal contents.
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